In the News
PPD Collaborates With Biopharma Company On Oncology, Immunology Therapies
Harbour BioMed (HBM) has selected PPD as its preferred global contract research partner to conduct clinical studies on its internal research pipelines.
Harbour BioMed, PPD pen cancer and immunology drug development collab
Biotech Harbour BioMed has teamed up with CRO PPD to work on creating new oncology and immunology meds.
Wilmington pharma nabs contract with global oncology outfit
North Carolina CRO has landed a contract with a global biopharmaceutical company with a quickly expanding research portfolio – adding to the firm's prestige in oncology and immunology development.
ADC characterization
Christopher Bianchetti, Henry Parker, Kit Hanson and Stephen Gacheru discuss the potential of antibody-drug conjugates for the biopharmaceutical industry.
Five-year study to examine how healthy brains age: ‘Research is urgently needed,’ says AES
PPD business unit Accelerated Enrollment Solutions initiates the Synexus HealthyMinds Registry, which aims to register 30,000 adults for the study.
PPD group launches major dementia study, to include 30,000 people
Dawie Wessels discusses the five-year study to explore ways to prevent and treat dementia.
PPD expands patient access to clinical trials via collaboration with cancer center
New collaboration expands opportunities for cancer patients to be treated in the community setting.
PPD teams up with Cancer Treatment Centers of America to boost oncology trials
Krystyna Kowalczyk explains that the collaboration creates meaningful opportunities for cancer patients to participate in clinical trials and access innovative therapies close to home
Good laboratory practices: Getting on the same page
Stuart Jones discusses the importance of training and other factors that can significantly impact quality.
